Jan 24, 2023 | biosimilars, health policy |
Ontario is the latest province to introduce a biosimilars switching policy. Under the terms of the policy, Ontario Drug Benefit (ODB) recipients who are on an originator biological will be required to transition to a Health Canada approved biosimilar version of the...
